SUBSCRIBE
Drivetime Radio

Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.

Current programs include:

  • Neurology – hosted by Prof Mark Cook, Neurologist, Melbourne
  • Ophthalmology – hosted by Prof Paul Mitchell, Ophthalmologist, Sydney
  • Psychiatry – hosted by Prof Malcolm Hopwood, Psychiatrist, Melbourne
  • Respiratory – hosted by Prof John Upham, Respiratory Physician, Brisbane

More disciplines coming soon……

Podcasts are available for each series – providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions

You can also listen online – either search by your area of interest to filter interviews relevant to you, or if you are logged in you can click on specific programs below.

Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.

Search Interviews

By area of interest:

Specialty Interviews

Resp.1Patient centred care in idiopathic pulmonary fibrosis (22 mins)
00:00
Preview
10 seconds
Show more information

Respiratory. Idiopathic pulmonary fibrosis, the disease course can be unpredictable, progressing rapidly in some patients and quite slowly in others. Patients need to know about the diagnosis and the treatment, to be informed about survival and palliative care, and what life is going to be like. So at what point do you give this information?

Hosted by

Professor John Upham

Interviewees

  • Dr Marlies Wijsenbeek, Pulmonary Physician. Erasmus University, Rotterdam, The NetherlandsDr Marlies Wijsenbeek, Pulmonary Physician. Erasmus University, Rotterdam, The Netherlands
Resp.2Treatment of idiopathic pulmonary fibrosis (25 mins)
00:00
Preview
10 seconds
Show more information

Respiratory. A lot has changed in the world of pulmonary fibrosis in the last few years, in terms of what treatments are available and what this means for our patients. We now have options to slow disease progression down and to prolong life, listen to learn more.

Hosted by

Professor John Upham

Interviewees

  • A/Prof Tamera Corte, Interstitial Lung Disease Specialist, Royal Prince Alfred Hospital, SydneyA/Prof Tamera Corte, Interstitial Lung Disease Specialist, Royal Prince Alfred Hospital, Sydney
Psyc.1Schizophrenia: How much of an impact can we make on our patients with an intervention? (16 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry: Evidence-based medicine and treatment effectiveness are important considerations when treating individuals with schizophrenia. We don’t have a medicine cookbook, instead we need our clinical experience and knowledge, together with the relevant evidence. In this interview we discuss how to evaluate the evidence that is presented to us.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Dr Leslie Citrome, Clinical Trialist, New York Medical College, USADr Leslie Citrome, Clinical Trialist, New York Medical College, USA
Psyc.2What do we know about Post-Traumatic Stress Disorder and Comorbidities? (23 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry. Trauma is much more common than people often estimate it to be, so why do some people present with PTSD after trauma while others don’t? This is just one of the questions covered in this comprehensive interview with Prof. McFarlane, who’s research has focused on the epidemiology and longitudinal course of PTSD as well as the neuroimaging of the cognitive deficits in this disorder.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Prof. Sandy McFarlane, Centre for Traumatic Stress Studies, University of AdelaideProf. Sandy McFarlane, Centre for Traumatic Stress Studies, University of Adelaide
Psyc.1Navigating treatment choice for patients with schizophrenia (18 mins)
00:00
Preview
10 seconds
Show more information

NEW Psychiatry. Patients with schizophrenia want the same things we want in life, they want to return back to life, having a sense of purpose, being able to have their symptoms improve, where they can go back to having relationships with those around them. How can we achieve this post-discharge from hospital?

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Prof. Greg Mattingly, Psychiatrist & Psychopharmacologist, St Louis, MissouriProf. Greg Mattingly, Psychiatrist & Psychopharmacologist, St Louis, Missouri
Psyc.2Why is it important to maintain patient functionality when treating people with major depression? (15 mins)
00:00
Preview
10 seconds
Show more information

NEW Psychiatry. In this interview we speak with Prof. Roger McIntyre, named as one of ‘The World’s Most Influential Scientific Minds’! We discuss the heterogeneous nature of depression and how to minimise residual symptoms, such as tiredness or the inability to concentrate when treating depression.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Prof. Roger McIntyre, Professor of Psychiatry and Pharmacology, University of Toronto, CanadaProf. Roger McIntyre, Professor of Psychiatry and Pharmacology, University of Toronto, Canada
Neu.1Key considerations when stepping up therapy for Parkinson’s Disease (29 mins)
00:00
Preview
10 seconds
Show more information

NEW Neurology. How can we fill the gap between available therapies and more advanced technologies used to treat Parkinson’s? In this interview we discuss how to manage patients experiencing unpredictable off periods out in the community, as well as the involvement of movement disorder clinics and the necessary assistance and infrastructure.

Hosted by

Professor Mark Cook

Interviewees

  • David Tsui, Clinical Nurse Consultant in Parkinson’s Disease & Movement Disorders, Westmead Hospital, SydneyDavid Tsui, Clinical Nurse Consultant in Parkinson’s Disease & Movement Disorders, Westmead Hospital, Sydney
Neu.2Device-Assisted Therapy for Parkinson’s disease (30 mins)
00:00
Preview
10 seconds
Show more information

NEW Neurology. Where do we go when patients continue to have symptoms? In this interview we discuss the practicalities of continuous infusions, intestinal gels and deep brain stimulation, including key considerations when deciding between them and the need for early identification and education.

Hosted by

Professor Mark Cook

Interviewees

  • A/Prof. John O’Sullivan, Visiting Neurologist, The Movement Disorders Service, Royal Brisbane & Women’s HospitalA/Prof. John O’Sullivan, Visiting Neurologist, The Movement Disorders Service, Royal Brisbane & Women’s Hospital
Resp.1Biologic therapy for severe refractory eosinophilic asthma – more questions answered with NEW long-term evidence (20 mins)
00:00
Preview
10 seconds
Show more information

NEW Respiratory. When you are seeing patients with asthma and airway disease in your clinical practice, if those patients are either; having frequent exacerbations or on maximum dose therapy, ask yourself, could this person have severe refractory eosinophilic asthma, and if so, could they benefit from one of the biologics? We review results from new long-term data that supports their use in clinical practice.

Hosted by

Professor John Upham

Interviewees

  • Prof. Peter Gibson, University of Newcastle, Hunter Medical Research Institute, John Hunter Hospital, NewcastleProf. Peter Gibson, University of Newcastle, Hunter Medical Research Institute, John Hunter Hospital, Newcastle
Resp.2What’s NEW in the management of severe asthma? An overview of the new GINA pocket guide (27 mins)
00:00
Preview
10 seconds
Show more information

NEW Respiratory. As respiratory physicians we need to be across the latest information available, especially for patients with difficult to treat or severe asthma, the types of patients that are often referred to us for specialist assessment and management. This is where GINA, the Global Initiative for Asthma, comes in. In this interview we talk through the new GINA pocket guide in relation to strategies to treat severe asthma.

Hosted by

Professor John Upham

Interviewees

  • Prof. Helen Reddel, Respiratory Physician, & Research Leader, the Woolcock Institute of Medical Research, University of SydneyProf. Helen Reddel, Respiratory Physician, & Research Leader, the Woolcock Institute of Medical Research, University of Sydney

Search Interviews

By area of interest:

Exclusively for Australian healthcare professionals
×

Tap the share icon ios share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!